Genital Herpes the Horror
Genital Herpes: The Horror
Herpes simplex virus (HSV) infection primarily causes mucocutaneous lesions and is typically episodic, but physical damage can occur in a range from mild to severe depending on the site of infection, the host’s immune status, and complications.
Primary effects at the infection site
Vesicles and ulcers: HSV produces painful fluid-filled blisters that break down into shallow ulcers. These lesions can cause localized tissue loss, scarring (less common with HSV-1 and HSV-2 on mucosa but possible on skin), and pigment changes.
Pain and inflammation: Acute episodes generate significant inflammation, causing tenderness, erythema, swelling, and neuralgia (pain along affected nerves).
Secondary bacterial infection: Broken skin and ulcers are vulnerable to bacterial superinfection, which can deepen tissue injury and prolong healing.
Complications by anatomical site
Genital (HSV-2 and HSV-1): Genital ulcers can be painful and, in severe cases, lead to erosions that complicate urination or sexual activity. Repeated episodes may cause post-inflammatory pigment changes or scarring, though significant scarring is uncommon in immunocompetent individuals.
Eye (herpes keratitis): HSV infection of the cornea is a leading cause of infectious blindness in developed countries. Recurrent epithelial infection and immune-mediated stromal disease can cause corneal scarring, thinning, vascularization, and vision loss if untreated.
CNS (herpes encephalitis): HSV-1 can cause fulminant, necrotizing encephalitis with rapid, often severe brain tissue destruction. Survivors may have significant neurological deficits (memory loss, cognitive impairment, focal deficits, seizures).
Neonatal herpes: When HSV is transmitted to a newborn, it can cause disseminated infection with skin, eye, mouth lesions, severe CNS disease, and visceral organ involvement. This can lead to permanent neurodevelopmental impairment, scarring, or death.
Disseminated infection in immunocompromised hosts: People with weakened immunity (HIV/AIDS, organ transplant recipients, chemotherapy patients) can develop widespread mucocutaneous disease, deep-tissue involvement, or visceral herpes causing organ damage.
Long-term and secondary effects
Post-herpetic neuropathic pain: Although classic “post-herpetic neuralgia” is associated with varicella-zoster virus rather than HSV, HSV-related neuropathic pain and persistent dysesthesia can occur along affected sensory nerves after lesions resolve.
Psychological and sexual health impact: Chronic or recurrent genital herpes can cause anxiety, relationship stress, decreased sexual wellbeing, and reduced quality of life—factors that may indirectly affect physical health (sleep disruption, stress-related immune changes).
Increased susceptibility to HIV: Genital ulcers and mucosal disruption from HSV increase risk of acquiring or transmitting HIV, with serious long-term implications in co-infected individuals.
Prevention of physical damage and management
Early antiviral therapy: Prompt use of oral or topical antivirals (acyclovir, valacyclovir, famciclovir) reduces lesion duration, severity, viral shedding, and risk of complications—especially important for ocular, neonatal, or CNS infections.
Suppressive therapy: Daily antiviral suppression can reduce recurrence frequency and transmission risk, lowering cumulative tissue injury over time.
Eye-specific care: Herpes keratitis requires ophthalmologic evaluation; timely antiviral and sometimes anti-inflammatory therapy reduces scarring risk.
Obstetric management: Cesarean delivery and antiviral suppression in late pregnancy may be recommended to prevent neonatal transmission when active genital lesions or prodrome are present.
Immunocompromised patients: Aggressive antiviral treatment, sometimes intravenous, and immune restoration where possible, reduce risk of severe tissue damage.
Key takeaways
For most healthy people, HSV causes episodic lesions that heal with minimal permanent tissue damage, but certain sites (cornea, central nervous system, neonate) and immunosuppression substantially increase the risk of serious, sometimes permanent physical harm.
Early recognition and appropriate antiviral treatment are central to preventing or minimizing physical damage from herpes infections.
